Chinese Pharmaceuticals & Biotech Spotless Management

Results

0 new

Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.

2 companies

Shanghai Allist Pharmaceuticals

Market Cap: CN¥42.8b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

688578

CN¥95.10

11.9%

2.2%

Xiamen Amoytop Biotech

Market Cap: CN¥22.1b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

688278

CN¥54.14

-3.0%

-25.0%